KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Beginning Cash BalanceCash from Discontinued OperationsCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TherapeuticsMD (TXMD) Net Cash Flow: 2010-2025

Historic Net Cash Flow for TherapeuticsMD (TXMD) over the last 15 years, with Sep 2025 value amounting to $999,000.

  • TherapeuticsMD's Net Cash Flow rose 1507.04% to $999,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.1 million, marking a year-over-year increase of 216.12%. This contributed to the annual value of $1.2 million for FY2024, which is 105.87% up from last year.
  • Per TherapeuticsMD's latest filing, its Net Cash Flow stood at $999,000 for Q3 2025, which was up 162.20% from $381,000 recorded in Q2 2025.
  • TherapeuticsMD's Net Cash Flow's 5-year high stood at $57.1 million during Q1 2021, with a 5-year trough of -$140.8 million in Q2 2022.
  • Over the past 3 years, TherapeuticsMD's median Net Cash Flow value was -$71,000 (recorded in 2024), while the average stood at -$1.6 million.
  • Per our database at Business Quant, TherapeuticsMD's Net Cash Flow soared by 5,515.14% in 2021 and then plummeted by 437.54% in 2022.
  • Quarterly analysis of 5 years shows TherapeuticsMD's Net Cash Flow stood at $47.8 million in 2021, then tumbled by 270.95% to -$81.8 million in 2022, then surged by 96.38% to -$3.0 million in 2023, then spiked by 100.57% to $17,000 in 2024, then spiked by 1,507.04% to $999,000 in 2025.
  • Its Net Cash Flow stands at $999,000 for Q3 2025, versus $381,000 for Q2 2025 and $699,000 for Q1 2025.